Filing Flows › Comparisons › DXCM vs WST
DexCom vs West Pharmaceutical Services: DXCM and WST compared
DexCom is the larger company: $1.3B of revenue in its latest quarter (Q3 2026) against $874M for West Pharmaceutical Services (Q3 2026). DexCom is growing faster (+11% against +9% a year earlier). West Pharmaceutical Services is more profitable, with an operating margin of 30.6% against 24.3%.
Where the money goes: DXCM and WST
DexCom (DXCM) · Q3 2026
DexCom, Q3 2026: revenue $1.3B (+11% year over year), operating margin 24.3%, net earnings $275M, operating cash flow $326M. The chart follows the revenue to costs, profit and cash.
West Pharmaceutical Services (WST) · Q3 2026
West Pharmaceutical Services, Q3 2026: revenue $874M (+9% year over year), operating margin 30.6%, net earnings $214M, operating cash flow $190M. The chart follows the revenue to costs, profit and cash.
| DexCom (DXCM) | West Pharmaceutical Services (WST) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $1.3B | $874M |
| Revenue growth, Y/Y | +11% | +9% |
| Gross margin | 64.3% | 39.7% |
| Operating margin | 24.3% | 30.6% |
| Net earnings | $275M | $214M |
| Net margin | 20.5% | 24.5% |
| Operating cash flow | $326M | $190M |
| Free cash flow | $273M | $150M |
| Market value | $30.6B | $28.3B |
| P/E | 31.5× | 44.9× |
| Analysts’ mean target | $98.15 | $471.00 |
Where the revenue comes from
West Pharmaceutical Services
- Proprietary Products: $729M (83%)
- West Vantage: $146M (17%)
Questions
Which is bigger, DexCom or West Pharmaceutical Services?
DexCom is the larger company: $1.3B of revenue in its latest quarter (Q3 2026) against $874M for West Pharmaceutical Services (Q3 2026).
Is DexCom or West Pharmaceutical Services growing faster?
DexCom is growing faster (+11% against +9% a year earlier).
Which is more profitable, DexCom or West Pharmaceutical Services?
West Pharmaceutical Services is more profitable, with an operating margin of 30.6% against 24.3%.
More: DexCom earnings · how DexCom makes money · West Pharmaceutical Services earnings · how West Pharmaceutical Services makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 29, 2026; 10-Q filed Oct 29, 2026). Fiscal quarters can end on different dates. Not investment advice.